PODD
Insulet Corporation
NASDAQ: PODD · HEALTHCARE · MEDICAL DEVICES
$160.02
-12.50% today
Updated 2026-04-29
Market cap
$11.08B
P/E ratio
46.12
P/S ratio
4.09x
EPS (TTM)
$3.47
Dividend yield
—
52W range
$158 – $355
Volume
1.0M
WallStSmart proprietary scores
59
out of 100
Grade: C+
Hold
Investment rating
8.0
Growth
A6.8
Quality
B7.5
Profitability
B+4.0
Valuation
C5/9
Piotroski F-Score
Moderate
2.3
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$326.35
+103.94%
12-Month target
$104.44
-34.73%
Intrinsic (DCF)
$167.73
Margin of safety
-49.56%
5 Strong Buy17 Buy1 Hold0 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $48.20M — positive
+ Revenue growth 31.20% QoQ
Risks
- 49.56% above intrinsic value
- P/E 46.12x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.31B | $1.70B | $2.07B | $2.71B | $2.71B |
| Net income | $4.60M | $206.30M | $418.30M | $247.10M | $101.60M |
| EPS | — | — | — | — | $3.47 |
| Free cash flow | $-38.30M | $70.10M | $305.40M | $377.70M | $48.20M |
| Profit margin | 0.35% | 12.16% | 20.19% | 9.12% | 9.12% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-01 | PANOS, MICHAEL | Buy | 7,255 | — |
| 2026-04-01 | PANOS, MICHAEL | Buy | 2,777 | — |
| 2026-03-31 | HUFFINES, ROBERT LUTHER | Buy | 111 | $209.84 |
Peer comparison
Smart narrative
Insulet Corporation trades at $160.02. representing a P/E of 46.12x trailing earnings. Our Smart Value Score of 59/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 2.31, it sits in the grey zone. TTM revenue stands at $2.71B. with profit margins at 9.12%. Our DCF model estimates intrinsic value at $167.73.
Frequently asked questions
What is Insulet Corporation's stock price?
Insulet Corporation (PODD) trades at $160.02.
Is Insulet Corporation overvalued?
Smart Value Score 59/100 (Grade C+, Hold). DCF value $167.73.
What is the price target of Insulet Corporation (PODD)?
The analyst target price is $326.35, representing +103.9% upside from the current price of $160.02.
What is the intrinsic value of Insulet Corporation (PODD)?
Based on our DCF model, intrinsic value is $167.73, a -49.6% margin of safety versus $160.02.
What is Insulet Corporation's revenue?
TTM revenue is $2.71B.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
2.31 — grey zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.09x
ROE18.10%
Beta1.47
50D MA$218.99
200D MA$283.20
Shares out0.07B
Float0.07B
Short ratio—
Avg volume1.0M
Performance
1 week-5.55%
1 month-12.09%
3 months-29.18%
YTD-35.66%
1 year—
3 years—
5 years—